Principal Financial Group Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$1.06 - $1.67 $23,533 - $37,075	22,201 Added 20.16%	132,302 $153,000
Q4 2023 Feb 07, 2024	SELL	$1.26 - $1.79 $25,493 - $36,217	-20,233 Reduced 15.52%	110,101 $186,000
Q3 2023 Nov 02, 2023	BUY	$1.61 - $2.54 $12,073 - $19,047	7,499 Added 6.1%	130,334 $235,000
Q2 2023 Aug 07, 2023	BUY	$1.14 - $1.95 $38,690 - $66,181	33,939 Added 38.18%	122,835 $228,000
Q1 2023 May 09, 2023	BUY	$1.2 - $2.19 $982 - $1,793	819 Added 0.93%	88,896 $118,000
Q4 2022 Feb 09, 2023	SELL	$1.63 - $3.52 $233,932 - $505,179	-143,517 Reduced 61.97%	88,077 $148,000
Q3 2022 Nov 09, 2022	BUY	$0.73 - $3.74 $3,893 - $19,949	5,334 Added 2.36%	231,594 $722,000
Q2 2022 Aug 10, 2022	BUY	$2.2 - $4.2 $497,772 - $950,292	226,260 New	226,260 $538,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.